stars 1 stars 2 stars 3

Founded in 1976, SOPHYSA is a French company pioneer in the development of adjustable neurosurgical valves, the most advanced type of valves for the treatment of Hydrocephalus. Indeed, they offer the possibility to neurosurgeons to adjust the operating pressure non-invasively depending on patient's clinical needs. Two adjustable valves are produced by SOPHYSA: the Sophy® Mini valve, which was the first adjustable valve in the world, launched in 1985, and the Polaris® valve, the first MRI-stable adjustable valve. In addition to a complete range of neurosurgical implants, SOPHYSA offers a continuous intracranial pressure measurement system required for patients with a trauma brain injury, hydrocephalus, and hematoma. Pressio® ICP monitoring system is a user-friendly monitor with its range of catheters for intracranial pressure and temperature measurements.

SOPHYSA Questions

The SOPHYSA annual revenue was $37.4 million in 2026.

Adrien Mignauw is the Global Sales and Marketing Director of SOPHYSA.

119 people are employed at SOPHYSA.

The NAICS codes for SOPHYSA are [33, 339].

The SIC codes for SOPHYSA are [384, 38].

Top SOPHYSA Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users